CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 27,600 | -43.4% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 48,800 | -6.2% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 52,000 | +10.6% | 0.00% | – |
| Q1 2022 | $3,000 | -89.7% | 47,000 | -28.5% | 0.00% | -100.0% |
| Q4 2021 | $29,000 | +7.4% | 65,700 | +19.9% | 0.00% | 0.0% |
| Q3 2021 | $27,000 | +3.8% | 54,800 | -22.9% | 0.00% | – |
| Q2 2021 | $26,000 | -46.9% | 71,100 | -35.9% | 0.00% | -100.0% |
| Q1 2021 | $49,000 | +48.5% | 110,900 | +142.1% | 0.00% | +200.0% |
| Q4 2020 | $33,000 | -21.4% | 45,800 | -7.8% | 0.00% | -50.0% |
| Q3 2020 | $42,000 | -91.9% | 49,700 | -74.0% | 0.00% | -93.1% |
| Q2 2020 | $521,000 | +3156.2% | 190,800 | +527.6% | 0.03% | +2800.0% |
| Q1 2017 | $16,000 | – | 30,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |